Complete MOVE Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
MOVE Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 5 peer companies in Healthcare
P/E Ratio
$-12.38
-2096.6%
Peer Median: 31.4x
EV/EBITDA
$0.00
-100.0%
Peer Median: 22.4x
P/S Ratio
$0.07
-88.1%
Peer Median: 0.5x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for MOVE's business model and current situation.
Multiple Comparison
| Multiple | MOVE Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -1.6x | 31.4x | 31.4x | -105.0% | Undervalued |
| EV/EBITDA | -Infinityx | 22.4x | 22.4x | -Infinity% | Undervalued |
| P/S Ratio | 4.3x | 0.5x | 2.5x | 739.2% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 0.5x | |
| $0.01B | 0.0x | 0.0x | 0.2x | |
| $0.00B | 0.0x | 0.0x | 4.3x | |
| $0.00B | 0.0x | 0.0x | 0.0x | |
| $3033.01B | 31.4x | 22.4x | 7.6x |